Skip to content
Search
Please enter at least 3 characters.

Latest Stories

PSNC chief Dukes assures contractors will receive Covid-related payments early October

Pharmaceutical Services Negotiating Committee chief executive Simon Dukes has assured that all pharmacy contractors will receive payments for their Covid-related costs early next month with the “overwhelming majority” getting paid in full.

“At the start of October, we expect that every single contractor will receive a payment from NHS BSA (NHS Business Services Authority)” with almost 95 per cent of them receiving their claims in full, Dukes said during the LPC Conference 2021 on Thursday, September 16.


“It will provide a much needed financial certainty for the vast majority of contractors,” he added. Very small number of contractors, around five per cent, whose claims form an outlier, will be contacted by the NHSBSA before the payment is released.

He reiterated that the total Covid-related claims far exceeded the original government cap of £120 million, and stressed that the negotiator was working out final details of the payment with concerned departments.

In June, the PSNC announced that contractors would have until August 15 to make claims for the pandemic related costs they incurred between March 2020 and March 2021.

Meanwhile, the sector has to pay back the £370m advance funding given to recognise contractors’ cashflow pressures during the pandemic.

He added that PSNC would soon make a formal announcement on this.

Pharmacy role

Lauding the role pharmacies played during the pandemic, Dukes said: “Our sector played a huge part in helping to prop up primary care through the NHS in the most difficult period.”

And, there is much more the sector needs to do over the coming weeks and months, he added.

“We heard the first signals from the minister that the NHS is expected to have another difficult winter. The chief medical officer reminded us of how, how quickly the situation worsened. And politicians once again spoke of the need to avoid overwhelming the NHS.

“(It) goes without saying Covid challenges will continue to impact on community pharmacies, testing the resilience of businesses, both financially and operation. We will need to maintain our focus on helping them (NHS) to manage the day job.”

Prime minister Boris Johnson on Tuesday (September 14), revealed the government’s plan to manage Covid throughout autumn and winter, which includes offering booster jabs to millions.

Besides the Covid management plan, community pharmacies will also have a pivotal role to play in the new national contractual framework services that are due to rollout this financial year including the long awaited expansion of new medicine service (NMS).

The NMS expansion along with the catch up facility will allow 1000s more people to benefit from a pharmacist advice, he said.

Dukes added that pharmacists can play a significant role in the smoking cessation and the community pharmacist consultation service. Both the services put pharmacies at the heart of the local NHS systems.

“I believe both will be critical to making future business cases about the value of the sector to government. Hospitals and GPs, once they start using the services properly, will not be able to afford to lose.”

Besides, referrals are expected to increase with the rollout of these services.

Hypertension case-finding service is another key achievement of the PSNC’s negotiations. Many contractors would want to offer this and make a significant contribution to the nation's health, Dukes said.

He added: “In short, it will add yet another item to the list of reasons why the NHS simply cannot cope without this sector.”

“And to have all of this rolled out alongside coping with the incredible pressures of the pandemic is nothing short of spectacular.”

“I hope that this transformation starts to give pharmacy the leverage it needs to enter future negotiations.”

Future negotiations

Reiterating his frustration with the government’s intransigence over uplifting the Community Pharmacy Contractual Framework (CPCF) funding Dukes said the future negotiations won’t be easy.

The negotiator’s proposal to increase funding for the sector was “flatly rejected by Treasury”, keeping the allocation unchanged at £2.592 billion for the year 2021/22.

He noted that the demand to increase sector’s funding coincided with the government discussions ahead of the upcoming budget.

He added: “We are not going to enter future negotiations until we have conducted the annual review. The annual review was stated very clearly in the initial CPCF document in 2019.”

For the next year CPCF negotiations, a lot of focus will be on rise in salaries, increase in national insurance, inflation along with capacity building initiatives for pharmacies.

He further cautioned about the changes that the new Health and Care Bill could bring.

“The new systems and structures will alter the local landscape and could quite radically change the way in which local services have permission.”

PSNC has called for a fair representation of pharmacy and other primary care providers in new health and care systems.

The Health and Care Bill that is currently being considered in parliament would shift the responsibility for managing contracts for primary NHS services to new Integrated Care boards (ICBs).

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less